Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Tamsulosin 0.4 Mg Caps 1000 By Zydus Pharma.

Image 0 of Tamsulosin 0.4 Mg Caps 1000 By Zydus Pharma.Image 1 of Tamsulosin 0.4 Mg Caps 1000 By Zydus Pharma.

Tamsulosin 0.4 Mg Caps 1000 By Zydus Pharma.

Call for Price

Tamsulosin 0.4 Mg Caps 1000 By Zydus Pharma. This Item Requires A Valid Order From A Physician Licensed in USA. Item Number.:RXD4374302/RXB10091822
Size : 1000
Selling UoM : EA
NDC: 68382-0132-10
UPC Barcode : 368382132109
Supplier: 0050001385 ZYDUS PHARMACEUTICALS (PGN)
Supplier Material : 013210
Generic Code : 027546 TAMSULOSIN HCL ORAL CAP ER 24H 0.4 MG
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals
Product Type : GRX Generic RX

Have a question?

  Call for Price

Product Description.:

ZA-18, 0.4mg
capsule , green peach , oblong oblong
Contains white to off-white pelletsBlack ink

tamsulosin hydrochloride Capsules, 0.4 mg DRUG DESCRIPTION Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate. Tamsulosin hydrochloride is (-)-(R)-5-[2-[[2-(o-Ethoxyphenoxy) ethyl]amino]propyl]-2-methoxybenzenesulfonamide, monohydrochloride. Tamsulosin hydrochloride is a white crystalline powder that melts with decomposition at approximately 230?C. It is sparingly soluble in water and methanol, slightly soluble in glacial acetic acid and ethanol, and practically insoluble in ether. Each FLOMAX capsule for oral administration contains tamsulosin hydrochloride 0.4 mg, and the following inactive ingredients: methacrylic acid copolymer dispersion, NF microcrystalline cellulose, NF triacetin, USP calcium stearate, NF talc, USP FD&C blue No. 2 titanium dioxide ferric oxide gelatin, and trace amounts of black edible ink. INDICATIONS Flomax? (tamsulosin hydrochloride) capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies]. FLOMAX capsules are not indicated for the treatment of hypertension. SIDE EFFECTS Clinical Trials Experience Because clinical studies are conducted under widely varying conditions, adverse reactions rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice. The incidence of treatment-emergent adverse events has been ascertained from six short-term U.S. and European placebo-controlled clinical trials in which daily doses of 0.1 to 0.8 mg FLOMAX capsules were used. These studies evaluated safety in 1783 patients treated with FLOMAX capsules and 798 patients administered placebo. Table 1 summarizes the treatment-emergent adverse events that occurred in ≥ 2% of patients receiving either FLOMAX capsules 0.4 mg or 0.8 mg and at an incidence numerically higher than that in the placebo group during two 13-week U.S. trials (US92-03A and US93-01) conducted in 1487 men.